Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
March 23 2022 - 8:00AM
Business Wire
Bone Biologics Corporation (NASDAQ: BBLG), a
developer of orthobiologic products for spine fusion markets, today
announced that Jeffrey Frelick, the Company’s president and chief
executive officer, has been invited to present at the 2022 Virtual
Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
on March 28 - 30, 2022. A pre-recorded presentation will be
available for 72 hours beginning Monday, March 28th at 9:00 a.m.
Eastern time. Interested parties may access a webcast of the
presentation on the investor relations section of the Company’s
website and at this link.
The conference will be live on M-Vest. To attend, sign up here
to become an M-Vest member.
About Bone Biologics
Bone Biologics was founded to pursue regenerative medicine for
bone. The Company is undertaking groundbreaking work with select
strategic partners, building on unprecedented research on the
Nell-1 protein that has produced a significant number of studies
and publications in peer reviewed scientific literature. Bone
Biologics is currently focusing its development efforts for its
bone graft substitute product on bone regeneration in spinal fusion
and has rights to trauma and osteoporosis applications. For more
information, please visit www.bonebiologics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220323005225/en/
LHA Investor Relations Kim Sutton Golodetz 212-838-3777
kgolodetz@lhai.com
Bone Biologics (NASDAQ:BBLG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bone Biologics (NASDAQ:BBLG)
Historical Stock Chart
From Sep 2023 to Sep 2024